"Haven't Made Any False Presentation To Media": Pharma Firm's CEO On Eye Drop Claim
Taking serious note of Mumbai-based Entod Pharmaceuticals' claims that it can help reduce dependency on reading glasses for those suffering from presbyopia, the Drugs Controller General of India (DGCI) has suspended permission given to the company to manufacture and sell their new eye drop, PresVU. The CEO of PresVu, Nikhil Masurkar, told NDTV that "they have not made any false presentation or facts to the media about the claims. We have talked about it to be a therapeutic option in Presbyopia. A common person does not understand what Presbyopia is and we explained it in the press conference, which led to a media hype and confusion."
